Skip to main content
Jeffrey R. Colin

Jeffrey R. Colin has wide-ranging experience litigating intellectual property matters in a variety of industries including pharmaceuticals, biotechnology, biologics, medical devices, and consumer electronics. Jeffrey has experience litigating patent infringement cases arising under the Hatch-Waxman Act and pertaining to drugs for treating various diseases including benign prostatic hyperplasia, migraines, pain, high triglycerides, acne, cold/flu, attention deficit hyperactivity disorder, irritable bowel syndrome, and hepatic encephalopathy. Jeffrey has participated in all stages of patent litigation, including formulating litigation strategy, overseeing day-to-day case management, overseeing complex e-discovery, fact and expert discovery, motion practice, trial and appeal. Jeffrey has also provided general intellectual property counseling to clients, conducted due diligence analyses, and drafted freedom to operate opinions.

Concentrations

  • Patent litigation
  • ANDA Hatch-Waxman litigation
  • General IP counseling, licensing, due diligence, opinions, and inter partes review proceedings
  • Trade secret litigation

Capabilities

Experience

  • Uniloc USA, Inc., et al. v. Samsung Electronics America, Inc., et al. (E.D. Tex.): Defended Samsung in a patent infringement case alleging infringement of a patent directed to video processing of Samsung’s SmartTVs.
  • Uniloc USA, Inc., et al. v. Samsung Electronics America, Inc., et al. (E.D. Tex.): Defended Samsung in a patent infringement case alleging infringement of a patent directed to the lock screen feature of Samsung’s smartphones.
  • Uniloc USA, Inc., et al. v. Samsung Electronics America, Inc., et al. (E.D. Tex.): Defended Samsung in a patent infringement case alleging infringement of a patent directed to reconfigurable communication networks.
  • Uniloc USA, Inc., et al. v. Samsung Electronics America, Inc., et al. (E.D. Tex.): Defended Samsung in 4 patent infringement cases alleging infringement of patents concerning Bluetooth, LTE and other communication protocols.
  • Baxter Healthcare Corp. v. B. Braun Medical Inc., et al. (E.D. Pa): Defended B. Braun against patent infringement claims relating to acute renal therapy kidney dialysis devices.
  • Wall v. B. Braun Interventional Systems Inc., et al. (N.D. Tex.): Defended B. Braun against patent infringement claims relating to cardiovascular stent technologies. Settled prior to fact discovery.
  • Mallinckrodt IP Unlimited et al. v. B. Braun Medical Inc. (D. Del.): Represented B. Braun in a 505(b)(2) Paragraph IV challenge of the OFIRMEV intravenous paracetamol formulation and manufacturing process patents. Settled following Markman ruling in favor of B. Braun and invitation by the district court judge to file for summary judgment.
  • Becton, Dickinson and Company v. B. Braun Melsungen AG: Represented B. Braun with respect to 8 inter partes review petitions concerning patents related to intravenous catheters.
  • Research and Design Assistant, Columbia University Biomaterials and Interface Tissue Engineering Lab, 2004
  • Judicial Intern, Hon. Thomas C. Platt, Senior U.S. District Court Judge, U.S. District Court for the Eastern District of New York, 2006
  • Intern, King’s County District Attorney’s Office, Early Case Assessment Bureau, 2004

Credentials

Education
  • J.D., Benjamin N. Cardozo School of Law, 2008
    • Articles Editor, Cardozo Arts & Entertainment Law Journal
  • B.S., Chemical Engineering, Columbia University, 2005
Admissions
  • New York
  • U.S. District Court for the Southern District of New York
  • U.S. District Court for the Eastern District of New York
  • U.S. District Court for the Eastern District of Texas
  • U.S. Court of Appeals for the Federal Circuit